Results 31 to 40 of about 372,210 (165)

A longitudinal study examining how self-injection social norms are associated with contraceptive self-injectable interest and use in rural Uganda [PDF]

BMC Women's Health
Background There is mounting evidence that social norms affect attitudes, decision-making, and behaviors related to contraceptive use. Integral to the self-care movement for women to have more control over their reproductive health, subcutaneous depot ...
Erica Sedlander, Nitya Turaga, Catherine Birabwa, Ronald Wasswa, Beth Phillips, Dinah Amongin, Sneha Challa, Sylvie Nano, Betty Kyobe, Agnes Kayego, Peter Waiswa, Kelsey Holt   +11 more
doaj   +2 more sources

Knowledge, confidence and social support: Kenyan women’s priority needs for contraceptive self-injection learning through a social cognitive theory lens [PDF]

BMC Women's Health
Background Self-injectable contraceptives provide individuals the opportunity to prevent pregnancy with a self-controlled method that helps enhance self-care.
Serah Gitome, Lauren Suchman, Sarah Okumu, Pauline Wekesa, Janelli Vallin, Louisa Ndunyu, Zachary A. Kwena, Jenny Liu, Kelsey Holt, Elizabeth A. Bukusi   +9 more
doaj   +2 more sources

An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa [PDF]

Contraception, 2018
Julie H Hernández, Pierre Z Akilimali, Arsene Binanga   +2 more
exaly   +2 more sources

Self-injected contraceptives: does the investment reflect women’s preferences?

BMJ Global Health, 2022
Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is an innovative contraceptive method aimed at meeting women’s unique circumstances and needs, largely due to its ability to be self-injected.
Sophia Magalona, Pierre Akilimali, Philip Anglewicz, Peter Gichangi, Elizabeth Omoluabi, Funmilola OlaOlorun, Georges Guiella, Shannon N. Wood, Linnea A. Zimmerman   +8 more
doaj   +1 more source

Testing a counseling message for increasing uptake of self-injectable contraception in southern Malawi: A mixed-methods, clustered randomized controlled study

PLoS ONE, 2022
Objective While self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has well-documented benefits, uptake may be improved by addressing client concerns such as fear of self-injury and low self-efficacy.
Holly M. Burke, Catherine Packer, Akuzike Zingani, Philemon Moses, Alissa Bernholc, Lucy W. Ruderman, Andres Martinez, Mario Chen   +7 more
doaj   +2 more sources

Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda. [PDF]

Glob Health Sci Pract, 2018
Reproductive Health Uganda (RHU), a local NGO, introduced subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana Press) in 4 districts of Uganda between April 2016 and March 2017.
Odwe G, Gray K, Kyarimpa A, Obare F, Nagendi G.   +4 more
europepmc   +2 more sources

Introduction of DMPA-SC self-injection in Ghana: A feasibility and acceptability study using Sayana® Press

, 2020
This research report describes results from an implementation science study that explored the feasibility and acceptability of administering depot medroxyprogesterone acetate-subcutaneous (DMPA-SC) among health-care providers and family planning (FP ...
Dela Nai, Patrick Aboagye, Kamil Fuseini, Elizabeth Tobey, Aparna Jain, Nora Maresh, Rebecca Fertziger   +6 more
openaire   +4 more sources

DMPA

, 2022
DMPA-SC is a lower-dose, easy-to-use injectable contraceptive. A trained person can administer it, including women through self-injection. This systematic review aims to assess the effectiveness of self- versus provider-administered contraceptive DMPA-SC
Ashraf Nabhan
core   +1 more source

Malawi DMPA-SC counselling code reports.

, 2023
Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC.
Frehiwot Birhanu (17507395), Fannie Kachale (3841615), Jessie Salamba Chirwa (17507398), Melinda Stanley (10511401), Andrews Gunda (5537063), Chelsey Porter Erlank (17507389), Gracious Ali (17507392)   +6 more
core   +1 more source

Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review

Systematic Reviews, 2023
Background Self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception (DMPA-SC) is registered in many countries. It shows great potential for improving contraceptive access, continuation, and autonomy.
Adeniyi Kolade Aderoba, Petrus Schoken Steyn, James Njogu Kiarie   +2 more
doaj   +1 more source